Details for 2019773583

Up to date per 01.04.2026

Actions

Title / Product Name

CHRONISCHE NÄCHTLICHE DOSIERUNG VON LASMIDITAN ZUR MIGRÄNEPRÄVENTION

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2019773583

EP Publication Number

3846810

E-Number

1621824

Language

PCT Number

US19049340

Publication Date

14.07.2021 A

18.10.2023 B1

Registration Date

18.10.2023

AT Publication Date

15.11.2023

Application Date

03.09.2019

Registration Number

Priorities

04.09.2018

201862726585 P

IPC

A61K 31/444 20060101AFI20200313BHEP

Maximum Duration of Protection

03.09.2039

Owner

Eli Lilly and CompanyLilly Corporate Center Indianapolis, IN 46285US

Representative

Schwarz & Partner Patentanwälte GmbHWipplingerstraße 301010 WienAT

Inventor

CONLEY, Robert Russellc/o ELI LILLY AND COMPANY P.O. Box 6288 Indianapolis, Indiana 46206-6288US

DAVAR, Gudarzc/o ELI LILLY AND COMPANY P.O. Box 6288 Indianapolis, Indiana 46206-6288US

JOHNSON, Kirk Willisc/o ELI LILLY AND COMPANY P.O. Box 6288 Indianapolis, Indiana 46206-6288US

Information about Fees